| 11571 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11572 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11573 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11574 |
ROLE OF IL-6, sIL-6R, IL-β, TNF-α, AND B2M IN PATHOPHYSIOLOGY AND PROGNOSIS OF MULTIPLE MYELOMA |
Department of Clinical Pathology |
2007 |
| 11575 |
SERUM HYALURONIC ACID (HA) AS A NEW NON INVASIVE MARKER FOR ASSESSING HEPATIC FIBROSIS & CIRRHOSIS |
Department of Medical Physiology |
2007 |
| 11576 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Dermatology |
2007 |
| 11577 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Clinical Pathology |
2007 |
| 11578 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Clinical Pathology |
2007 |
| 11579 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Clinical Pathology |
2007 |
| 11580 |
Serum lipid, Apo E genotypes and tumer necrosis factor alpha in Psoriatic arthritis patients: In relation to disease activity |
Department of Clinical Pathology |
2007 |